Efficacy of Photodynamic Therapy as a Treatment for Gorlin Syndrome-related Basal Cell Carcinomas

Clinical Oncology

Volumn 21, Issue 6, 2009, Pages 502-508

  Loncaster, J ^a   Swindell, R ^a   Slevin, F ^a   Sheridan, L ^a   Allan, D ^a   Allan, E ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Basal cell carcinoma; Gorlin syndrome; naevoid basal cell carcinoma syndrome; NBCCS; optical fibre diffuser laser; photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PHOTOFRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; B SCAN; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER CONTROL; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; BASAL CELL NEVUS SYNDROME; CHILD; DIHEMATOPORPHYRIN ETHER; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; YOUNG ADULT;

EID: 67649646239     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.03.004     Document Type: Article

References (26)

1. Gorlin R.J., and Goltz R.W. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib syndrome. N Engl J Med 262 (1960) 908-912
2. Bale A.E., and Yu K.P. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 10 7 (2001) 757-762
3. Epstein Jr. E. Genetic determinants of basal cell carcinoma risk. Med Pediatr Oncol 36 (2001) 555-558
4. Grachtchouk M., Yu Z., Sasaki H., et al. Basal cell carcinomas in mice over-expressing Gli2 in skin. Nat Genet 24 (2004) 216-217
5. Gorlin R.J. Naevoid basal-cell carcinoma syndrome. Medicine (Baltimore) 66 (1987) 98-113
6. Kimonis V.E., Goldstein A.M., Pastakia B., et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 69 (1997) 299-308
7. Shanley S., Ratcliffe J., Hockey A., et al. Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. Am J Med Genet 50 (1994) 282-290
8. Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic therapy. J Natl Cancer Inst 90 (1998) 889-905
9. Fingar V.H. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 14 (1996) 323-328
10. Loncaster J.A., Moore J.V., Allan D., and Allan E. An ultrasound analysis of the response of Gorlin syndrome-related and sporadic basal cell carcinomas to aminolaevulinic acid photodynamic therapy. Photodiagn Photodyn Ther 2 (2005) 149-155
11. Rhodes L.E., de Rie M.A., Leifsdottir R., et al. Five-year follow-up of a randomized prospective trial of methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 143 9 (2007) 1131-1136
12. Morton C.A., MacKie R.M., Whitehurst C., Moore J.V., and McColl J.H. Photodynamic therapy for basal cell carcinoma: effect of tumour thickness and duration of photosensitizer application on response. Arch Dermatol 134 (1998) 248-249
13. Madan V., Loncaster J.A., Allan D., et al. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser. J Am Acad Dermatol 55 (2006) S86-S89
14. Loncaster J.A., and Allan E. Photodynamic therapy in the management of a patient with Gorlin syndrome (naevoid basal cell carcinoma syndrome). Photodiagn Photodyn Ther 3 (2006) 134-137
15. Smeets N.W., Krekels G.A., Ostertag J.U., et al. Surgical excision vs Moh's micrographic surgery for basal cell carcinoma of the face: randomised controlled trial. Lancet 364 (2004) 1766-1772
16. 2 used for the successful treatment of basal cell carcinomas found in patients with basal cell nevus syndrome. Dermatol Surg 28 (2002) 287-290
17. Doctoroff A., Oberlender S.A., and Purcell S.M. Full-face carbon dioxide laser resurfacing in the management of a patient with the nevoid basal cell carcinoma syndrome. Dermatol Surg 29 (2003) 1236-1240
18. Stockfletch E., Ulrich C., Hauschild A., et al. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol 12 (2002) 569-572
19. Micali G., Lacarrubba F., Nasca M.R., and De Pasquale R. The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clin Exp Dermatol 28 (2003) 19-23
20. Ferreres J.R., Macaya A., Jucgla A., et al. Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream. J Eur Acad Dermatol Venereol 20 (2006) 877-878
21. Geisse J., Caro I., Lindholm J., et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase 3, randomised vehicle-controlled studies. J Am Acad Dermatol 50 (2004) 722-733
22. Braathen L.R., Szeimies R.-M., Basset-Seguin N., et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 56 (2007) 125-143
23. Oseroff A., Sheih S., Frawley N., et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamatomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 141 (2005) 60-67
24. Itkin A., and Gilchrest B.A. δ-Aminolevulinic acid and blue light photodynamic therapy for the treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg 30 (2004) 1054-1061
25. Smucler R., and Vlk M. Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma. Lasers Surg Med 40 (2008) 153-158
26. 2 laser with photodynamic therapy for the treatment of nodular basal cell carcinomas. Ann Plastic Surg 59 (2007) 484-488